The establishment and development of a Greek biotechnology cluster would most likely impact society as a whole as a result of the provision of high quality health services and products both locally and internationally. Bionian Cluster constitutes a recently established health sciences cluster in Greece and SEE. The Cluster has been established within Greece. The Cluster aims to contribute substantially to regional economic development by overcoming the divide between academic research hubs and related stakeholders of the private industry. The scope of the Cluster’s activities target primarily SEE countries, while aspiring to emerge as an important stakeholder in the Middle East/ North African (MENA) region
The vision of the Bionian Cluster is to bring Greece to the forefront of biotechnology worldwide in two main themes: (a) the Biomedical Sciences, with a focus on applied clinical research, clinical pharmacology and therapeutics, and(b) the Environmental Health Sciences (EHS), with a focus on the reduction of the burden of human illness and disability through a better understanding of the impact of environmental factors and exposures on disease pathogenesis and progression, as well as on general human health.
- Membership at the National Biotechnology Committee on ETAK-ESPA Appropriation Funds, 2007-2013 (EU 7th Framework Program), of the General Secretariat in Research and Technology, Ministry of Development (2007 - 2009)
- Mapping of the National Biomedical Innovation in Greece (up to 2009), along with the Human Capital on relevant sectors in Biotechnology and Biosciences in Greece and the Greek Diaspora
- Organizing educational and training sessions, scientific conferences, public awareness events, publishing in highly-acclaimed scientific journals and editing two Scientific Journals in the fields of Biotechnology and Life Sciences (Βio, MedReview) from 2006 to date
- Working in close collaboration with the Hellenic National Contact Point ("Health" and "Food, Agriculture and Fisheries & Biotechnology"), in EU-funded projects on Health and Biotechnology
- Signing "Memoranda of Understanding" (MoU) between Hellenic and foreign Biotech firms, Clusters and Academic / Research Institutions worldwide, as with China, Egypt, Russia, Saudi Arabia, U.S.A. (National Institutes of Health, N.I.H.), Bulgaria.
- Establishing and organizing the International Greek Biotechnology Forum (IGBF) in Greece for the last 5 years (2004-2009)
- Collaborating with the Hellenic Biotechnology Association, for creation of a Biotechnology -- Health Cluster in Greece, by recruiting top ranked Academic and Research Institutions, as well as Technological Organizations to join forces for common objectives
- Cooperating with the N.I.H. (U.S.A.), to ensure official rights by our Network for unlimited access to 1) NIH educational infrastructure and resources to organize and administer courses and seminars on Research Methodologies, Clinical Pharmacology and Principles in Clinical Research, based on syllabi and educational material currently in use at the N.I.H., leading to official certification, 2) extended privileged access to technology transfer and original patent applications filed at the N.I.H. Patent Office, to fuel our Translational Research machinery.
"Bionian Cluster, the First Health Sciences Cluster in Greece & South - East Europe, is a unique, well balanced concentration of leading businesses, universities, medical research institutes, academic institutions, hospitals and biosciences in Greece and other countries all over the world."
The recent establishment in Greece of the Bionian Cluster, a multinational conglomerate constituted by academic research centers, pharmaceutical companies, and private industry stakeholders, seeks to overcome the vast aforementioned adversities in biotechnology and health sciences related research fields. It is by this means that the Bionian Cluster aspires to develop into an active regional and international stakeholder for the development of innovative health sciences alliances and market-driven smart specialization solutions. The present work aims to detail the key characteristics and implementation challenges faced by the Bionian Cluster, as well as how these may be effectively overcome. Aggressive networking to optimize coordination of multidisciplinary innovation efforts will prime cooperation between leading Greek research institutions, biomedical researchers of the Greek diaspora and private enterprises. It is aspired that the establishment of the Bionian Cluster will contribute to the development of a novel scientific environment and mode of conduct conducive to business-oriented innovation in SEE.
7Research Organisations, Universities, Technology Centers
0Other Ecosystem Actors